Articles related to Hepatology

Analysis of 285,680 patients shows a 1.03-1.38% reduction in cumulative mortality with rosuvastatin compared to atorvastatin, alongside varying risks for cardiovascular events, liver outcomes, and diabetes.

A 2023 study found that participants who consumed fast food for 20% or more of their meals accumulated excessive fat in their livers, highlighting the potential impact of dietary choices on liver health.

The STRIDE regimen demonstrated a 30.7% survival rate at 36 months, compared to 20.2% with sorafenib, suggesting potential long-term benefits for patients with unresectable hepatocellular carcinoma.

The TOPAZ-1 trial demonstrates that adding durvalumab to standard chemotherapy significantly improves overall survival in patients with advanced biliary tract cancer, potentially establishing a new first-line treatment option for this difficult-to-treat malignancy.

An estimated 5% of U.S. adults have consumed at least one potentially hepatotoxic herbal supplement in the past month, raising concerns about liver health risks associated with unregulated botanical products.

Emerging data suggest that lactated Ringer’s is associated with improved health outcomes and may be superior to normal saline in acute pancreatitis management.